Division of Colon and Rectal Surgery, University of Chicago, Room J557F, MC 5095, 5841 S. Maryland Ave, Chicago, IL, 60637, USA.
J Gastrointest Surg. 2020 Oct;24(10):2349-2356. doi: 10.1007/s11605-020-04694-4. Epub 2020 Jun 25.
Colorectal cancer is the result of multiple genetic mutations that drive normal cells to adenoma and then carcinoma. Recent technology has evolved to allow for an in-depth examination of the microbiota and it has become clear that many components of the intestinal microbiome play a role in promoting carcinogenesis. This review aims to describe the potential mechanisms that lead to the dysbiosis that initiates tumor formation and that influence the development of cancer recurrence following surgical resection. We further discuss how manipulation of the microbiome may be a future novel strategy to prevent both primary and secondary colorectal cancer. While we discuss how bacterial communities and individual strains can promote cancer, the microbiome is individualized, dynamic, and complex, and our understanding of its role in carcinogenesis is still in its infancy.
结直肠癌是多种基因突变的结果,这些突变导致正常细胞变成腺瘤,然后再变成癌。最近的技术已经发展到可以深入研究微生物组,现在已经清楚的是,肠道微生物组的许多成分在促进致癌作用中发挥作用。这篇综述旨在描述导致启动肿瘤形成的失调以及影响手术切除后癌症复发发展的潜在机制。我们进一步讨论了如何操纵微生物组可能成为预防原发性和继发性结直肠癌的未来新策略。虽然我们讨论了细菌群落和个别菌株如何促进癌症,但微生物组是个体化的、动态的和复杂的,我们对其在致癌作用中的作用的理解还处于起步阶段。